{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:45:32Z","timestamp":1791812732420,"version":"4.3.4"},"reference-count":29,"publisher":"The Pediatric Pharmacy Association","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.5863\/jppt-26-00021","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:51:07Z","timestamp":1791809467000},"page":"711-714","source":"Crossref","is-referenced-by-count":0,"title":["3D Printing and Automated Compounding to Improve Pediatric Pharmacy Practice"],"prefix":"10.5863","volume":"31","author":[{"given":"Sophia","family":"Tilley","sequence":"first","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Brasher","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Brooke","family":"Bernhardt","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","reference":[{"issue":"11","key":"JPPT-26-00021-b01","series-title":"Pharmaceutics","first-page":"1364","article-title":"Three-dimensional printing in paediatrics: innovative technology for manufacturing patient-centred drug delivery systems","volume":"17","author":"Cou\u0163i","year":"2025","unstructured":"Cou\u0163i N, Iurian S, Porfire A, et al. Three-dimensional printing in paediatrics: innovative technology for manufacturing patient-centred drug delivery systems. Pharmaceutics. 2025;17(11):1364."},{"issue":"1","key":"JPPT-26-00021-b02","series-title":"Pediatrics","first-page":"e2025073604","article-title":"Access to pediatric-friendly formulations at the time of pediatric labeling and after marketing","volume":"157","author":"Abdel-Rahman","year":"2025","unstructured":"Abdel-Rahman SM, Avant DA, Burckart GJ. Access to pediatric-friendly formulations at the time of pediatric labeling and after marketing. Pediatrics. 2025;157(1):e2025073604."},{"issue":"10","key":"JPPT-26-00021-b03","series-title":"Acta Paediatr","first-page":"2480","article-title":"Challenges and considerations in manipulating oral dosage forms in paediatric healthcare settings: a narrative review","volume":"114","author":"Paulsson","year":"2025","unstructured":"Paulsson M, Hamre Svendsen R, Andersen JKN, et al. Challenges and considerations in manipulating oral dosage forms in paediatric healthcare settings: a narrative review. Acta Paediatr. 2025;114(10):2480\u20132489."},{"key":"JPPT-26-00021-b04","article-title":"General chapter <800> hazardous drugs\u2014handling in healthcare settings","year":"2019","unstructured":"United States Pharmacopeial Convention. General chapter <800> hazardous drugs\u2014handling in healthcare settings. 2019. Accessed February 13, 2026. https:\/\/www.usp.org\/compounding\/general-chapter-hazardous-drugs-handling-healthcare"},{"key":"JPPT-26-00021-b05","series-title":"Ann 3D Print Med","first-page":"100035","article-title":"Integration of 3D printing technology in pharmaceutical compounding: progress, prospects, and challenges","volume":"4","author":"Melnyk","year":"2021","unstructured":"Melnyk LA, Oyewumi MO. Integration of 3D printing technology in pharmaceutical compounding: progress, prospects, and challenges. Ann 3D Print Med. 2021;4:100035."},{"key":"JPPT-26-00021-b06","series-title":"J Control Release","first-page":"367","article-title":"Semi-solid extrusion 3D printing in drug delivery and biomedicine: personalised solutions for healthcare challenges","volume":"332","author":"Seoane-Via\u00f1o","year":"2021","unstructured":"Seoane-Via\u00f1o I, Januskaite P, Alvarez-Lorenzo C, et al. Semi-solid extrusion 3D printing in drug delivery and biomedicine: personalised solutions for healthcare challenges. J Control Release. 2021;332:367\u2013389."},{"key":"JPPT-26-00021-b07","article-title":"General chapter <795> pharmaceutical compounding\u2014nonsterile preparations. 2024","unstructured":"United States Pharmacopeial Convention. General chapter <795> pharmaceutical compounding\u2014nonsterile preparations. 2024. Accessed February 13, 2026. www.usp.org\/usp-healthcare-professionals\/compounding\/general-chapter-795"},{"key":"JPPT-26-00021-b08","series-title":"Int J Pharm","first-page":"124306","article-title":"Developing an innovative 3D printing platform for production of personalised medicines in a hospital for the OPERA clinical trial","volume":"661","author":"Denis","year":"2024","unstructured":"Denis L, J\u00f8rgensen AK, Do B, et al. Developing an innovative 3D printing platform for production of personalised medicines in a hospital for the OPERA clinical trial. Int J Pharm. 2024;661:124306."},{"key":"JPPT-26-00021-b09","series-title":"Int J Pharm","first-page":"125581","article-title":"Clinical implementation of a paediatric 3D-printed combination of sulfamethoxazole and trimethoprim","volume":"676","author":"Stoops","year":"2025","unstructured":"Stoops M, Do B, Ramos S, et al. Clinical implementation of a paediatric 3D-printed combination of sulfamethoxazole and trimethoprim. Int J Pharm. 2025;676:125581."},{"issue":"11","key":"JPPT-26-00021-b10","series-title":"J Fungi","first-page":"762","article-title":"Amphotericin B ocular films for fungal keratitis and a novel 3D-printed microfluidic ocular lens infection model","volume":"10","author":"Rapti","year":"2024","unstructured":"Rapti C, Luciano FC, Anaya BJ, et al. Amphotericin B ocular films for fungal keratitis and a novel 3D-printed microfluidic ocular lens infection model. J Fungi. 2024;10(11):762."},{"key":"JPPT-26-00021-b11","series-title":"Int J Pharm","first-page":"125149","article-title":"Stability enhancement of Amphotericin B using a 3D-printed biomimetic polymeric corneal patch to treat fungal infections","volume":"670","author":"Kailasam","year":"2025","unstructured":"Kailasam V, Hiremath MS, Sudharsan P, et al. Stability enhancement of Amphotericin B using a 3D-printed biomimetic polymeric corneal patch to treat fungal infections. Int J Pharm. 2025;670:125149."},{"issue":"5","key":"JPPT-26-00021-b12","series-title":"AAPS PharmSciTech","first-page":"159","article-title":"Formulation and characterization of a 3D-printed cryptotanshinone-loaded niosomal hydrogel for topical therapy of acne","volume":"21","author":"Wang","year":"2020","unstructured":"Wang Z, Liu L, Xiang S, et al. Formulation and characterization of a 3D-printed cryptotanshinone-loaded niosomal hydrogel for topical therapy of acne. AAPS PharmSciTech. 2020;21(5):159."},{"key":"JPPT-26-00021-b13","series-title":"Eur J Pharm Sci","first-page":"107122","article-title":"Semi-solid extruded tablets for personalized pediatric use: development, quality control, and in vitro assessment of enteral tube administration","volume":"211","author":"Bahman","year":"2025","unstructured":"Bahman M, Sandler Topelius N, Viitala T. Semi-solid extruded tablets for personalized pediatric use: development, quality control, and in vitro assessment of enteral tube administration. Eur J Pharm Sci. 2025;211:107122."},{"issue":"6","key":"JPPT-26-00021-b14","series-title":"Cancer","first-page":"1400","article-title":"Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia","volume":"107","author":"Taylor","year":"2006","unstructured":"Taylor JA, Winter L, Geyer LJ, Hawkins DS. Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia. Cancer. 2006;107(6):1400\u20131406."},{"key":"JPPT-26-00021-b15","series-title":"Int J Pharm","first-page":"125251","article-title":"Advancing medication compounding: use of a pharmaceutical 3D printer to auto-fill minoxidil capsules for dispensing to patients in a community pharmacy","volume":"671","author":"Rodr\u00edguez-Maci\u00f1eiras","year":"2025","unstructured":"Rodr\u00edguez-Maci\u00f1eiras X, Bendicho-Lavilla C, Rial C, et al. Advancing medication compounding: use of a pharmaceutical 3D printer to auto-fill minoxidil capsules for dispensing to patients in a community pharmacy. Int J Pharm. 2025;671:125251."},{"issue":"11","key":"JPPT-26-00021-b16","series-title":"Pharmaceutics","first-page":"1100","article-title":"I spy with my little eye: a paediatric visual preferences survey of 3D printed tablets","volume":"12","author":"Januskaite","year":"2020","unstructured":"Januskaite P, Xu X, Ranmal SR, et al. I spy with my little eye: a paediatric visual preferences survey of 3D printed tablets. Pharmaceutics. 2020;12(11):1100."},{"key":"JPPT-26-00021-b17","series-title":"Int J Pharm","first-page":"118497","article-title":"Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: first single-centre, prospective, crossover study in patients","volume":"567","author":"Goyanes","year":"2019","unstructured":"Goyanes A, Madla CM, Umerji A, et al. Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: first single-centre, prospective, crossover study in patients. Int J Pharm. 2019;567:118497."},{"key":"JPPT-26-00021-b18","article-title":"Best Pharmaceuticals for Children Act","unstructured":"Eunice Kennedy Shriver National Institute of Child Health and Human Development. Best Pharmaceuticals for Children Act. Accessed April 8, 2026. https:\/\/www.nichd.nih.gov\/research\/supported\/bpca"},{"key":"JPPT-26-00021-b19","unstructured":"US Food and Drug Administration. Pediatric Research Equity Act. Accessed April 8, 2026. https:\/\/www.fda.gov\/drugs\/development-resources\/pediatric-research-equity-act-prea"},{"key":"JPPT-26-00021-b20","article-title":"Guideline on pharmaceutical development of medicines for pediatric use","year":"2013","unstructured":"European Medicines Agency. Guideline on pharmaceutical development of medicines for pediatric use. 2013. Accessed April 10, 2026. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-pharmaceutical-development-medicines-paediatric-use_en.pdf"},{"issue":"3","key":"JPPT-26-00021-b21","series-title":"Pharmaceutics","first-page":"516","article-title":"Creating acceptable tablets 3D (CAT 3D): a feasibility study to evaluate the acceptability of 3D printed tablets in children and young people","volume":"14","author":"Bracken","year":"2022","unstructured":"Bracken L, Habashy R, McDonough E, et al. Creating acceptable tablets 3D (CAT 3D): a feasibility study to evaluate the acceptability of 3D printed tablets in children and young people. Pharmaceutics. 2022;14(3):516."},{"issue":"2","key":"JPPT-26-00021-b22","series-title":"Pharmaceutics","first-page":"416","article-title":"A review of 3D printing technology in pharmaceutics: technology and applications, now and future","volume":"15","author":"Wang","year":"2023","unstructured":"Wang S, Chen X, Han X, et al. A review of 3D printing technology in pharmaceutics: technology and applications, now and future. Pharmaceutics. 2023;15(2):416."},{"key":"JPPT-26-00021-b23","series-title":"Int J Pharm","first-page":"125760","article-title":"Beyond the hype: the potential and challenges of semi-solid extrusion 3D printing in pharmaceutical applications through the lens of Portuguese 3D experts","volume":"680","author":"Bom","year":"2025","unstructured":"Bom S, Cavaco A, Martins AM, et al. Beyond the hype: the potential and challenges of semi-solid extrusion 3D printing in pharmaceutical applications through the lens of Portuguese 3D experts. Int J Pharm. 2025;680:125760."},{"issue":"5","key":"JPPT-26-00021-b24","series-title":"Pharmaceutics","first-page":"678","article-title":"Automated non-sterile pharmacy compounding: a multi-site study in European hospital and community pharmacies with pediatric immediate release propranolol hydrochloride tablets","volume":"16","author":"Sandler Topelius","year":"2024","unstructured":"Sandler Topelius N, Shokraneh F, Bahman M, et al. Automated non-sterile pharmacy compounding: a multi-site study in European hospital and community pharmacies with pediatric immediate release propranolol hydrochloride tablets. Pharmaceutics. 2024;16(5):678."},{"key":"JPPT-26-00021-b25","series-title":"Adv Drug Deliv Rev","first-page":"39","article-title":"A new chapter in pharmaceutical manufacturing: 3D-printed drug products","volume":"108","author":"Norman","year":"2017","unstructured":"Norman J, Madurawe RD, Moore CM, et al. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev. 2017;108:39\u201350."},{"issue":"1","key":"JPPT-26-00021-b26","series-title":"J Oncol Pharm Pract","first-page":"71","article-title":"Advancing non-sterile pediatric pharmacotherapy through automated compounding and 3D printing of ondansetron hcl dihydrate dosage forms","volume":"32","author":"Bahman","year":"2026","unstructured":"Bahman M, Bernhardt MB, Brasher CA, et al. Advancing non-sterile pediatric pharmacotherapy through automated compounding and 3D printing of ondansetron hcl dihydrate dosage forms. J Oncol Pharm Pract. 2026;32(1):71\u201386."},{"issue":"6","key":"JPPT-26-00021-b27","series-title":"Pharmaceutics","first-page":"762","article-title":"Automated 3D printing-based non-sterile compounding technology for pediatric corticosteroid dosage forms in a health system pharmacy setting","volume":"17","author":"Bernhardt","year":"2025","unstructured":"Bernhardt MB, Shokraneh F, Hrizanovska L, et al. Automated 3D printing-based non-sterile compounding technology for pediatric corticosteroid dosage forms in a health system pharmacy setting. Pharmaceutics. 2025;17(6):762."},{"issue":"2","key":"JPPT-26-00021-b28","series-title":"Pharmacoecon Open","first-page":"207","article-title":"What does pharmaceutical 3D printing cost: a framework and case study with hydrocortisone for adrenal insufficiency","volume":"9","author":"Ayyoubi","year":"2025","unstructured":"Ayyoubi S, Ruijgrok L, van der Kuy H, et al. What does pharmaceutical 3D printing cost: a framework and case study with hydrocortisone for adrenal insufficiency. Pharmacoecon Open. 2025;9(2):207\u2013215."},{"issue":"5","key":"JPPT-26-00021-b29","series-title":"Clin Pharmacol Ther","first-page":"1125","article-title":"Development and bioequivalence of 3D-printed medication at the point-of-care: bridging the gap toward personalized medicine","volume":"113","author":"Lyousoufi","year":"2023","unstructured":"Lyousoufi M, Lafeber I, Kweekel D, et al. Development and bioequivalence of 3D-printed medication at the point-of-care: bridging the gap toward personalized medicine. Clin Pharmacol Ther. 2023;113(5):1125\u20131131."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/31\/5\/article-p711.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/31\/5\/article-p711.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/31\/5\/article-p711.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:51:07Z","timestamp":1791809467000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/31\/5\/article-p711.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":29,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.5863\/jppt-26-00021","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"value":"2331-348X","type":"electronic"},{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}